Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: Results of the DYSlipidemia International Study (DYSIS).

MLA

Shuiping Zhao, et al. “Prevalence of Dyslipidaemia in Patients Treated with Lipid-Lowering Agents in China: Results of the DYSlipidemia International Study (DYSIS).” Atherosclerosis (00219150), vol. 235, no. 2, Aug. 2014, pp. 463–69. EBSCOhost, https://doi.org/10.1016/j.atherosclerosis.2014.05.916.

APA

Shuiping Zhao, Yongjun Wang, Yiming Mu, Bilian Yu, Ping Ye, Xiaowei Yan, Zhanquan Li, Yidong Wei, Ambegaonakr, B. M., & Dayi Hu. (2014). Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: Results of the DYSlipidemia International Study (DYSIS). Atherosclerosis (00219150), 235(2), 463–469. https://doi.org/10.1016/j.atherosclerosis.2014.05.916

Chicago

Shuiping Zhao, Yongjun Wang, Yiming Mu, Bilian Yu, Ping Ye, Xiaowei Yan, Zhanquan Li, Yidong Wei, Baishaili M. Ambegaonakr, and Dayi Hu. 2014. “Prevalence of Dyslipidaemia in Patients Treated with Lipid-Lowering Agents in China: Results of the DYSlipidemia International Study (DYSIS).” Atherosclerosis (00219150) 235 (2): 463–69. doi:10.1016/j.atherosclerosis.2014.05.916.